CBM Wins Investment Deal of the Year at 30th Annual Enterprise Awards

The Philadelphia and surrounding region most prestigious celebration of achievement, innovation, and success for leaders in life sciences and technology

The Enterprise Awards remain the region’s most prestigious business honors for technology and life sciences companies, leaders, and entrepreneurs. Attracting prominent business leaders, the Enterprise Awards gala celebrates achievement, innovation, and success in the Greater Philadelphia region.

The Enterprise Awards are sponsored by Baker Tilly, Bank of America, Ben Franklin Technology Partners of Southeastern PA, BlankRome, Boomi, Broadpath, Comcast Business, Cozen O’Connor, DFIN Solutions, Duane Morris, EY, Fairmount Partners, Fox Rothschild, Independence Blue Cross, InstaMed/J.P. Morgan Chase, KPMG, Morgan Lewis, NewSpring Capital, Osage Ventures, RSM, Troutman Pepper, University City Science Center, University of Pennsylvania, Vanguard.

Watch the full awards ceremony below!

About The Center for Breakthrough Medicines (CBM)

Center for Breakthrough Medicines (CBM) is a purpose-built and patient-driven, cell and gene therapy contract development and manufacturing organization (CDMO) uniquely positioned to enable pharma and biotech companies to develop, test, and manufacture life-saving therapies on a global scale. Ideally located in the heart of Philadelphia’s Cellicon Valley, CBM has assembled the most accomplished cell and gene therapy experts in the world, armed with cutting-edge and innovative technologies, to offer scalable, end-to-end, best-in-class services from pre-clinical through commercial, including process development, plasmid DNA, vector manufacturing, cell banking, cell processing, and a full suite of complementary and standalone testing and analytical capabilities.